| Lot Release Number |
2020-01-21-0016
|
| FDA Registered Product/Generic Name |
Combined Diphtheria, Tetanus and Acellular Pertussis, Hepatitis B, Inactivated Poliomyelitis and Haemophilus influenzae Type B Vaccine (Preservative-free)
|
| Brand Name |
Infanrix Hexa
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension for Injection (I.M.)
|
| Registration Number |
BR-508
|
| Batch/Lot Number |
A21CD684 (DTPa-IPV-HepB: AC21B738C; HiB: AHIBD389A)
|
| Packaging Lot |
Packaging lot (box): A21CD684A
Pre-filled syringe: A21LD684A, MD 02-2019, ED 01-2022
Vial: A21FD684A, MD 04-2019, ED 03-2022;
Needles (25G x 1"): 1907007, ED 2024-0630
|
| Product Expiration Date |
31 January 2022
|
| Issuance Date |
23 January 2020
|